Navigation Links
Sub-Micron Gold Particles Are Superior to Larger Particles for Efficient Biolistic Transformation of Organelles and Some Cells

electron microscopy. Accurate size analysis of gold microparticles is particularly difficult because of their high density and their potential to agglomerate. Most suppliers of gold powder determine particle size by sedimentation techniques. This procedure has the advantage of analyzing a very large number of particles as well as being a rapid and relatively simple procedure. However, sedimentation analysis does not distinguish between individual and agglomerated particles, and particle diameter is estimated assuming perfectly spherical particles. While electron microscopy is more labor intensive, it permits visual determination of the particle shape and allows direct measurement of the diameter of individual particles. Therefore, non-spherical batches of gold particles can be excluded from further assay and agglomerated particles can be eliminated from the size calculation for maximum consistency between samples. Figure 1 shows scanning electron micrographs of gold and tungsten particles representative of the those sold by Bio-Rad. Also shown are size distributions for the four sets of particles used in these experiments. The contrast between the two types of particles in terms of the size and shape is particularly evident. Scanning electron microscopy has been used as a part of the quality control procedure to determine the average size, the variation in size, and the sphericity of Bio-Rad gold particles since 1993. Information on the average particle diameter, the standard deviation of the diameter, and the aspect ratio (the ratio of the long axis of the particle to the short axis of the particle a measure of sphericity) is provided with every lot of gold microparticles. Additionally, quality control includes
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Superior Gene Silencing Using Adenoviral Vectors
2. Delivery of pCMV-S DNA Using the Helios Gene Gun System Is Superior to Intramuscular Injection in Balb/c Mice
3. Calcium Plus Assay Kit, Superior Detection for Specialized Targets
4. The Affymetrix GeneChip Scanner 3000 New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range
5. PCR-Grade Nucleotides Larger Pack Sizes Now Available
6. Efficiently Insert Unique Restriction Sites into Plasmid Vectors
7. Efficient Cleavage of Fusion Proteins to Yield Native Amino Termini
8. Mammalian Expression Vector for Efficient Cloning of PCR Fragments
9. Efficient Transfection of Neurospora Crassa
10. Efficient Transfection of Neurospora Crassa
11. Efficient Recovery of Ultrapure Plasmid DNA

Post Your Comments:
(Date:11/6/2009)...f., Nov. 6 Intarcia Therapeutics, ... 650 (DUROS® continuous delivery of exenatide...the Ninth Annual Diabetes Technology Meeting in Sa...com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, Co...CA 650 Lowers Plasma Glucose, HbA1c and Reduces We...
(Date:11/5/2009)...olo., Nov. 5 The endangered black-...stern U.S. This rare carnivore feeds on prairie d...ague and often entire population die-offs in towns...) has implemented a ferret breeding program and ha...ir formerly native habitat. Unfortunately, plague...
(Date:11/5/2009)...ll on Thursday, November 5, 2009 at 4:30 p.m. East...PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals,...I ) today reported unaudited financial results for... 30, 2009 and reviewed the Company,s highlights fo...onsolidated results reflect the operations of Onco...
(Date:11/5/2009)...exas, Nov. 5 Wound Manag...that it has entered into a Letter of Intent to pur...lth Technologies, Inc. (OTC Bulletin Board: VHGI)....in cash and debt, 4,000,000 shares of WNDM and a r... the Veriscrip technology being acquired from VHGI...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret 2OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3
...sia/ -- Simcere Pharmaceutical Group,("Simcere" or...urer and supplier,of branded generic and innovativ...ed financial results for the quarter ended March 3...creased to RMB442.5 million (US$64.8 million) for ...lion for the corresponding, period in 2008, ...
...ls announces it has signed an agreement with HUYA ... enabling and accelerating global codevelopment of...ginating in China. , , Through this agreement, S...omprehensive Chinese molecule portfolio, focusing ...ea. As some of these molecules are already in adv...
...oratories, Inc., an emerging specialty pharmaceuti...ausea and vomiting (OINV) in opioid pharmaceutical... Exploratory Bioequivalence Study on CL-108, Charl...ising data on our immediate-release low-dose antie...icer at Charleston Laboratories, "and confirm our ...
Other Biology Technology:Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 2Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 3Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 4Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 5Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 6Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 7Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 8Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 9Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 10Simcere Pharmaceutical Group Reports Unaudited First Quarter 2009 Results 11Solvay Pharmaceuticals Announces Strategic Partnership With HUYA to Access new Drug Candidates From China 2Solvay Pharmaceuticals Announces Strategic Partnership With HUYA to Access new Drug Candidates From China 3Charleston Laboratories, Inc. Completes Exploratory Bioequivalence Study of CL-108 2
(Date:11/5/2009)...n, Conn.Researchers at Yale University have develo...ody,s immune response to HIV and HIV-infected cell...ings, published online in the Journal of the Amer...eutic approaches for these diseases. , The mole...ing HIV" (ARM-H) and "antibody-recruiting molecule...
(Date:11/4/2009)...PHIA Although scientists are reluctant to officia...d, evidence continues to grow about its protective...ed in Cancer Prevention Research , a journal of t... suggests some reduction in oral cancer. , Vass...ine in the Department of Thoracic/Head and Neck Me...
(Date:11/4/2009)...affic corridors in the cities of Long Beach and Ri...on of preventable childhood asthma, and the true i...isease has likely been underestimated, according t...rnia (USC). , The study, which appears in an on...alth , estimated that nine percent of all childhoo...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2USC study finds big air pollution impacts on local communities 2Any Day OK for Heart Bypass Surgery 58127 1Any Day OK for Heart Bypass Surgery 58127 2Data Strategy Invited to Become a Member of VMware 26apos 3Bs Partner Technical Advisory Board 28PTAB 29 58123 1Data Strategy Invited to Become a Member of VMware 26apos 3Bs Partner Technical Advisory Board 28PTAB 29 58123 2Healthcare Breach Notification Rules Take Effect 3B ID Experts Offers Complimentary Tool to Measure Organizations Breach Index 58119 1Healthcare Breach Notification Rules Take Effect 3B ID Experts Offers Complimentary Tool to Measure Organizations Breach Index 58119 2Healthcare Breach Notification Rules Take Effect 3B ID Experts Offers Complimentary Tool to Measure Organizations Breach Index 58119 3
...reat idea or invention but don,t know where to tur...ing day of four workshops for first-time entrepren...Center and the Alumni Association of NJIT. Set fo...30 a.m. 3 p.m., the event will feature many oppor...ch that dream. , "I Have an Idea, Now What?" is...
...ase, MDCigarette smoking during pregnancy is assoc...ernal and fetal thyroid function, according to a n... Society,s Journal of Clinical Endocrinology & Me...f cigarette smoking on thyroid function of two gro... in the first trimester and the other in the third...
...lle, NY, January 12, 2009The Academy of Breastfeed...ite, Facebook, would be well advised to review its...rs. Such a policy perpetuates the notion that brea... from public viewing, a misguided and antiquated c...It further perpetuates the idea that formula feedi...
Other Biology News:Entrepreneurs wanted for NJIT workshops about how to launch a business 2
Cat IgA ELISA Kit from Bethyl Laboratories
Cat IgM ELISA Kit from Bethyl Laboratories
Phosphatase Colorimetric Assay Kit from BioAssay Systems
Horse IgGb ELISA Kit from Bethyl Laboratories
Biology Products: